December 18, 2018

Vigene Biosciences announces partnership with Virovek to make high yield cGMP AAV production technology accessible and affordable.

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the […]
August 15, 2018

Vigene Biosciences Ranks 81st on the 2018 Inc. 5000.

ROCKVILLE, Md. Inc. magazine today revealed that Vigene Biosciences is No. 81 on its 37th annual Inc. 5000, the most prestigious […]
May 29, 2018

Vigene Biosciences Named Emerging Growth Company of the Year at 2018 Corporate Growth Awards.

ROCKVILLE, Md. Vigene Biosciences, Inc. has been recognized as the 2018 Emerging Growth Company of the Year by ACG National […]
November 7, 2017

Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson’s Disease Research

ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, today announced a […]
November 1, 2017

Vigene Biosciences and Mila’s Miracle Foundation announce partnership on Gene therapy for CLN7 Batten Disease

A race to save children’s lives from a devastating neurodegenerative disorder ROCKVILLE, Md. ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a […]
November 29, 2016

Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biologics

Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the company has […]